Lawrence J. Ellison Ambulatory Care Center
4860 Y St., Suite 2400
Sacramento, CA 95817
UC Davis Medical Group - Roseville (Douglas Boulevard)
2261 Douglas Blvd.
Roseville, CA 95661
Additional Phone Numbers
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Philosophy of Care
Dr. Lim believes that patients and their physicians should work together as a team to achieve their treatment goals. The more information a patient has regarding his or her disease, the more involved that patient will be in their own medical care. I encourage patients to ask questions about their glaucoma eye care in order to stay informed.
Dr. Lim is the Vice Chair and Medical Director for the UC Davis Eye Center. Her clinical interests focus primarily on the specialty care of glaucoma patients. Through innovative research on the medical and surgical treatment of glaucoma she is able to offer the latest techniques to protect her patient’s vision from this serious disease, including the newer minimally invasive glaucoma surgeries (MIGS).
Her area of glaucoma research includes patient adherence with glaucoma eye drop medications, the role of personality type and glaucoma, and the investigation of novel surgical techniques in the treatment of this disease.
As a member of the UC Davis Health System’s Electronic Health Record task force and the American Academy of Ophthalmology’s Medical Information Technology Committee, Dr. Lim is working to bring the latest in information technology to streamline the care of glaucoma patients.
She is a nationally and internationally invited speaker on the Electronic Health Record and it’s impact on the delivery of healthcare in ophthalmology. Dr. Lim is, likewise, active in national and international glaucoma clinical trials and is the recipient of several research grant awards.
Dr. Lim's area of glaucoma research includes optic nerve imaging (ocular coherence tomography, OCT), patient compliance with glaucoma eye drop medications, and the influence of personality type on glaucoma.
Dr. Lim is active in national and international glaucoma clinical trials and she is the recipient of several research grant awards.
M.D., UCLA School of Medicine, Los Angeles CA 1995
B.S., Cornell University, Ithaca NY 1989
Ophthalmology, Jules Stein Eye Institute, Los Angeles CA 1996-1999
Glaucoma, Bascom Palmer Eye Institute, Miami FL 1999-2000
American Board of Ophthalmology, 2000
American Academy of Ophthalmology
American Glaucoma Society
Honors and Awards
Best Doctors in Sacramento - 2005, 2011, 2012
UC Davis Health System Dean’s Award for Excellence in Clinical Care, 2008
Henry and Lillian Nesburn Research Award, Los Angeles Eye Society, 1999
Select Recent Publications
Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM, and the Ahmed Baerveldt Comparison Study Group. Five-Year Treatment Outcomes in the Ahmed Baerveldt Comparison Study. Ophthalmology, 2014 epub.
Barton K, Feuer WJ, Budenz DL, Schiffman J, Costa VP, Godfrey DG, Buys YM:. Ahmed Baerveldt Comparison Study Group Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study. Ophthalmology, 2014;121(8): 1547-1557.
Lim MC, Chiang MF, Boland MV, McCannel CA, Wedemeyer L, Epley KD, Silverstone DE, Saini A, Lum F [American Academy of Ophthalmology Medical Information Technology Committee]. Editorial: Meaningful Use: How did we do, where are we now, where do we go from here? Ophthalmology, 2014;121(9): 1667-1669.
Silverstone DE, Lim MC, American Academy of Ophthalmology Information Technology. Ensuring Information Integrity in the Electronic Health Records: The crisis and the challenge. Ophthalmology, 2014;121(2): 435-437.
Boland MV, Chiang MF, Lim MC. Adoption of Electronic Health Records and Preparation for Demonstrating Meaningful Use: An American Academy of Ophthalmology Survey. Ophthalmology, 2013;120(8): 1702-1710.
Lim MC, Watnik MR, Imson KR, Porter SM, Granier AM. Adherence to Glaucoma Medication: The Effect of Interventions and Association with Personality Type. J of Glaucoma, 2013;22(6): 439-446.
Gardiner SK, Demirel S, De Moraes CG et al.and OHTS Study Group. Series Length Used During Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study. Inve Ophthal & Vis Sci, 2013;54(2): 1252-1259.
Zangwill LM, Jain S, Dirkes K, He F, Medeiros FA, Trick GL, Brandt JD< Cioffi GA, Coleman AL, Liebmann JM, Piltz-Seymour JR, Gordon MO, Kass MA, Weinreb RN on behalf of the Confocal scanning laser ophthalmologoscopy ancilliary study to the Ocular Hypertension Treatment Study. The Rate of Structural Change: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Amer J of Ophthal, 2013;155(6): 971-982.
Craven ER, Katz LJ, Wells JM, Giamporcaro JE and the iStent Study Group. Cataract Surgery with Trabecular Micro-bypass Stent Implentation in Patients with Mild-to-moderate Open-Angle Glaucoma and Cataract: Two-Year Follow-Up. Cataract Refract Surg, 2012;38(8): 1339-1345.
De Moraes C, Demirel S, Gardiner SK, et al. Rate of Visual Field Progression in Eyes with Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study. Arch of Ophthal, 2012;130(12): 1541-1546.